Effect of iron overload on furin expression in wild-type and β-thalassemic mice

Toxicology Reports

Volumn 2, Issue , 2015, Pages 415-422

  Wichaiyo, Surasak ^a   Yatmark, Paranee ^a   Morales Vargas, Ronald Enrique ^b   Sanvarinda, Pimtip ^a   Svasti, Saovaros ^c   Fucharoen, Suthat ^c   Morales, Noppawan Phumala ^a  

^a Mahidol University   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Furin; Hepcidin; Iron overload; Thalassemic mice

Indexed keywords

ERYTHROPOIETIN; FURIN; HEPCIDIN; IRON DEXTRAN; MESSENGER RNA; TRANSFERRIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA THALASSEMIA; BLOOD ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; IRON OVERLOAD; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RNA ISOLATION; SEQUENCE ANALYSIS; WESTERN BLOTTING;

EID: 84925507151     PISSN: 22147500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxrep.2015.01.004     Document Type: Article

References (37)

1. Seidah N.G., Prat A. The biology and therapeutic targeting of the proprotein convertases. Nat. Rev. Drug Discov. 2012, 11:367-383.
2. Thomas G. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell Biol. 2002, 3:753-766.
3. Gagliardo B., Kubat N., Faye A., Jaouen M., Durel B., Deschemin J.C., Canonne-Hergaux F., Sari M.A., Vaulont S. Pro-hepcidin is unable to degrade the iron exporter ferroportin unless maturated by a furin-dependent process. J. Hepatol. 2009, 50:394-401.
4. Pietrangelo A. Hepcidin in human iron disorders: therapeutic implications. J. Hepatol. 2011, 54:173-181.
5. Scamuffa N., Basak A., Lalou C., Wargnier A., Marcinkiewicz J., Siegfried G., Chretien M., Calvo F., Seidah N.G., Khatib A.M. Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7. Gut 2008, 57:1573-1582.
6. Olivieri N.F. The beta-thalassemias. N. Engl. J. Med. 1999, 341:99-109.
7. Olivieri N.F., Brittenham G.M. Iron-chelating therapy and the treatment of thalassemia. Blood 1997, 89:739-761.
8. Nemeth E. Hepcidin in beta-thalassemia. Ann. N.Y. Acad. Sci. 2010, 1202:31-35.
9. Origa R., Galanello R., Ganz T., Giagu N., Maccioni L., Faa G., Nemeth E. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica 2007, 92:583-588.
10. Poli M., Luscieti S., Gandini V., Maccarinelli F., Finazzi D., Silvestri L., Roetto A., Arosio P. Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation. Haematologica 2010, 95:1832-1840.
11. Bondi A., Valentino P., Daraio F., Porporato P., Gramaglia E., Carturan S., Gottardi E., Camaschella C., Roetto A. Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload. Haematologica 2005, 90:1161-1167.
12. Jamsai D., Zaibak F., Khongnium W., Vadolas J., Voullaire L., Fowler K.J., Gazeas S., Fucharoen S., Williamson R., Ioannou P.A. A humanized mouse model for a common beta0-thalassemia mutation. Genomics 2005, 85:453-461.
13. Moon S.N., Han J.W., Hwang H.S., Kim M.J., Lee S.J., Lee J.Y., Oh C.K., Jeong D.C. Establishment of secondary iron overloaded mouse model: evaluation of cardiac function and analysis according to iron concentration. Pediatr. Cardiol. 2011, 32:947-952.
14. Reardon T.F., Allen D.G. Iron injections in mice increase skeletal muscle iron content, induce oxidative stress and reduce exercise performance. Exp. Physiol. 2009, 94:720-730.
15. Ginzburg Y.Z., Rybicki A.C., Suzuka S.M., Hall C.B., Breuer W., Cabantchik Z.I., Bouhassira E.E., Fabry M.E., Nagel R.L. Exogenous iron increases hemoglobin in beta-thalassemic mice. Exp. Hematol. 2009, 37:172-183.
16. Yatmark P., Morales N.P., Chaisri U., Wichiyo S., Hemstapat W., Srichairatanakool S., Saovaros S., Fucharoen S. Iron distribution and histopathological characterization of the liver and heart of β-thalassemic mice with parenteral iron overload: effects of deferoxamine and deferiprone. Exp. Toxicol. Pathol. 2014, 66:333-343.
17. Jamsai D., Zaibak F., Vadolas J., Voullaire L., Fowler K.J., Gazeas S., Peters H., Fucharoen S., Williamson R., Ioannou P.A. A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia. Genomics 2006, 88:309-315.
18. Rebouche C.J., Wilcox C.L., Widness J.A. Microanalysis of non-heme iron in animal tissues. J. Biochem. Biophys. Methods 2004, 58:239-251.
19. Sarradin P.M., Le Bris N., Le Gall C., Rodier P. Fe analysis by the ferrozine method: adaptation to FIA towards in situ analysis in hydrothermal environment. Talanta 2005, 66:1131-1138.
20. Frazer D.M., Wilkins S.J., Darshan D., Badrick A.C., McLaren G.D., Anderson G.J. Stimulated erythropoiesis with secondary iron loading leads to a decrease in hepcidin despite an increase in bone morphogenetic protein 6 expression. Br. J. Haematol. 2012, 157:615-626.
21. Mastrogiannaki M., Matak P., Mathieu J.R., Delga S., Mayeux P., Vaulont S., Peyssonnaux C. Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis. Haematologica 2012, 97:827-834.
22. Weizer-Stern O., Adamsky K., Amariglio N., Rachmilewitz E., Breda L., Rivella S., Rechavi G. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models. Am. J. Hematol. 2006, 81:479-483.
23. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
24. Waterborg J.H., Matthews H.R. The Lowry method for protein quantitation. Methods Mol. Biol. 1994, 32:1-4.
25. Sisto M., Lisi S., Lofrumento D.D., Ingravallo G., Mitolo V., D'Amore M. Expression of pro-inflammatory TACE-TNF-alpha-amphiregulin axis in Sjogren's syndrome salivary glands. Histochem. Cell Biol. 2010, 134:345-353.
26. Baschong W., Suetterlin R., Laeng R.H. Control of autofluorescence of archival formaldehyde-fixed, paraffin-embedded tissue in confocal laser scanning microscopy (CLSM). J. Histochem. Cytochem. 2001, 49:1565-1572.
27. Ohtake T., Saito H., Hosoki Y., Inoue M., Miyoshi S., Suzuki Y., Fujimoto Y., Kohgo Y. Hepcidin is down-regulated in alcohol loading. Alcohol. Clin. Exp. Res. 2007, 31:S2-S8.
28. Ginzburg Y., Rivella S. beta-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood 2011, 118:4321-4330.
29. Melchiori L., Gardenghi S., Rivella S. beta-Thalassemia: hijaking ineffective erythropoiesis and iron overload. Adv. Hematol. 2010, 2010:938640.
30. Rund D., Rachmilewitz E. Beta-thalassemia. N. Engl. J. Med. 2005, 353:1135-1146.
31. Gardenghi S., Marongiu M.F., Ramos P., Guy E., Breda L., Chadburn A., Liu Y., Amariglio N., Rechavi G., Rachmilewitz E.A., Breuer W., Cabantchik Z.I., Wrighting D.M., Andrews N.C., de Sousa M., Giardina P.J., Grady R.W., Rivella S. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 2007, 109:5027-5035.
32. Murphy A.T., Witcher D.R., Luan P., Wroblewski V.J. Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood 2007, 110:1048-1054.
33. Zhao N., Zhang A.S., Enns C.A. Iron regulation by hepcidin. J. Clin Investig. 2013, 123:2337-2343.
34. Valore E.V., Ganz T. Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin. Blood Cells Mol. Dis. 2008, 40:132-138.
35. Brisson B.K., Barton E.R. New modulators for IGF-I activity within IGF-I processing products. Front. Endocrinol. 2013, 4:42.
36. Papanikolaou G., Pantopoulos K. Iron metabolism and toxicity. Toxicol. Appl. Pharmacol. 2005, 202:199-211.
37. Vidergor G., Goldfarb A.W., Glaser B., Dresner-Pollak R. Growth hormone reserve in adult beta thalassemia patients. Endocrine 2007, 31:33-37.